1956-39-4

166089-99-2 Formaldehyde, polymers with bisphenol A, 2-(diethylamino)ethanol, melamine and melamine 2-(2-hydroxyethoxy)ethyl derivs.

18086-33-4 (2-ETHOXY-5-METHOXYPHENYL)-ACETIC ACID

180863-04-1 3-PYRIDINECARBOXYLIC ACID,2-ETHOXY-3,4,5,6-TETRAHYDRO-4-METHYL-,ETHYL ESTER

180889-34-3 METHANIMIDAMIDE,N-(1,2-DIHYDROXYETHYL)-N,N-DIMETHYL-,[R-(E)]-

166090-00-2 Carbonic acid, dimethylester, polymer with a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl),ether with polyethylene glycol monodecyl ether

18086-25-4 1-(2,4-Dihydroxyphenyl)-2-(2,5-dimethoxyphenyl)ethanone

180889-32-1 ETHANIMIDAMIDE,N-(1,2-DIHYDROXYETHYL)-N,N-DIMETHYL-,[R-(E)]-

180859-88-5 L-Arginine,N2-[N-[N-[N-[N-[N-[1-[1-(N2-D-arginyl-L-arginyl)-L-prolyl]-trans-4-hydroxy-L-prolyl]glycyl]-3-(2-thienyl)-L-alanyl]-L-seryl]-D-2-(2,3-dihydro-1H-inden-2-yl)glycyl]-N-(2,3-dihydro-1H-inden-2-yl)glycyl]-

180894-78-4 Octadecanoic acid,(1S)-1-[[(4-methoxyphenyl)methoxy]methyl]-2-[[1-oxo-6-[[(phenylmethoxy)carbonyl]amino]hexyl]oxy]ethyl ester

180894-18-2 L-Serine, N-[N-[bis(1-methylethoxy)phosphinyl]-L-histidyl]-

180895-43-6 HYDRAZINECARBOXYLIC ACID 2-(TRIFLUOROACETYL)-,METHYL ESTER

180868-14-8 2,4-Pentadienoic acid, 5-(5,6-dichloro-1H-indol-2-yl)-2-methoxy-,(2Z,4E)-

166089-32-3 Lintuzumab

1808-63-5 3beta-hydroxy-16-methylpregna-5,16-dien-20-one

18089-32-2 (20R)-11β,17-Dihydroxy-20,21-[isopropylidenebisoxy]pregna-1,4-dien-3-one

180889-29-6 Methanimidamide, N-(1,2-dihydroxyethyl)-N,N-dimethyl-, [R-(E)]- (9CI)

16607-58-2 3-(dimethylamino)-4,6-diphenylpyridin-2(1H)-one

180866-58-4 SP 16A

18088-13-6 1,1,1,3-TETRACHLOROOCTANE

16608-68-7 2-Butene, 3-chloro-1-phenyl-, (Z)-